Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Ocugen, Inc. | d817729ds1a.htm |
| EX-4.5 - EX-4.5 - Ocugen, Inc. | d817729dex45.htm |
| EX-4.7 - EX-4.7 - Ocugen, Inc. | d817729dex47.htm |
| EX-4.1 - EX-4.1 - Ocugen, Inc. | d817729dex41.htm |
| EX-1.1 - EX-1.1 - Ocugen, Inc. | d817729dex11.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated April 11, 2014, with respect to the consolidated financial statements of Histogenics Corporation contained in the Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption “Experts”.
/s/ Grant Thornton LLP
Boston, Massachusetts
November 7, 2014